Automated test system for viral loads and screening
Original notice title
Italy – Reagents and contrast media – FORNITURA DI UN SISTEMA COMPLESSO PER TEST IN AUTOMAZIONE PER LE VIREMIE PRINCIPALI (HIV-HBV-HCV-CMV) E SCREENING BATTERIOLOGICO PER MRSA E GBS IN BIOLOGIA MOLECOLARE QUANTITATIVA E QUALITATIVA NECESS
Opportunity Score
Why this score?
Opportunity
65 / 100
Complexity
50 / 100
Risk factors
No procurement documents were analyzed; essential details (technical specs, contract terms) are unknown.
Moderate submission timeline (approx. 5 weeks from publication).
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- AZIENDA USL DI BOLOGNA
- Country
- Italy
- CPV
- 33696000 - Reagents and contrast media
- Deadline
- Jun 25, 2026
- Estimated value
- EUR 784.8k
Overview
Moderate opportunityKey Facts
- EUR 784.8k estimated value
- Supplies contract
- 1 lot
- Duration 1095 DAY
- Supply automated system for viremia tests (HIV, HBV, HCV, CMV) and bacteriological screening (MRSA, GBS) using quantitative and qualitative molecular biology.
- System to be delivered to Azienda Ospedaliero Universitaria di Ferrara.
Show full summary
Open tender for the supply of an automated system for viremia tests (HIV, HBV, HCV, CMV) and bacteriological screening (MRSA, GBS) for the Microbiology Unit of Azienda Ospedaliero Universitaria di Ferrara. The buyer is Azienda USL di Bologna. Single lot, estimated value €784,790. Submission deadline 16 July 2026. Awarded on most economically advantageous basis (quality). Only notice data available; procurement documents not analyzed.
Risks
No procurement documents were analyzed; essential details (technical specs, contract terms) are unknown.
Moderate submission timeline (approx. 5 weeks from publication).
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Automated system for molecular biology testing.
- System must handle viremia tests (HIV, HBV, HCV, CMV).
- System must handle bacteriological screening (MRSA, GBS).
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Bologna, ITA
Buyer profile
Identifier
02406911202
Activity
Health
Lots (1)
LOT-0001
Sistema complesso per test viremie e screening batteriologico
Supply of an automated system for quantitative and qualitative molecular biology testing for HIV, HBV, HCV, CMV viremias and bacteriological screening for MRSA and GBS.
EUR 784.8k
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
Offerta economicamente più vantaggiosa
Value note
Show original TED data
Original TED description
Sistema complesso per test viremie e screening batteriologico
Procurement Details
- Publication date
- 07 Jun 2026
- Languages
- Italian
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 390496-2026
Documents (2)
Similar tenders
Poland – Analysers – Przetarg nieograniczony PN/18DzOL/09/2026 na dostawy odczynników wraz z dzierżawą automatycznego systemu do izolacji kwasów nukleinowych
Romania – Reagents and contrast media – ACORD CADRU DE FURNIZARE Reactivi şi produse de contrast si Reactivi pentru analize de sânge
Poland – Pharmaceutical products – Dostawa produktów farmaceutycznych i dietetycznych
Lithuania – Reagents and contrast media – Reagentai ir eksploatacinės medžiagos (Nr. 10913-16)
Poland – Chemical reagents – Wyłonienie Wykonawcy w zakresie sukcesywnej dostawy odczynników i materiałów zużywalnych dla jednostek organizacyjnych Uniwersytetu Jagiellońskiego (z wyłączeniem Collegium Medicum UJ).
Poland – Pharmaceutical products – produkty lecznicze w 309 pakietach dla potrzeb Apteki Szpitalnej Wojewódzkiego Szpitala Zespolonego w Elblągu
Opportunity Score
Why this score?
Opportunity
65 / 100
Complexity
50 / 100
Risk factors
No procurement documents were analyzed; essential details (technical specs, contract terms) are unknown.
Moderate submission timeline (approx. 5 weeks from publication).
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications